AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $183,000 | -98.5% | 15,884 | -98.7% | 0.00% | -97.7% |
| Q2 2019 | $12,286,000 | -26.9% | 1,229,705 | -5.7% | 0.04% | -30.6% |
| Q1 2019 | $16,803,000 | -10.0% | 1,304,639 | +6.4% | 0.06% | -26.2% |
| Q4 2018 | $18,678,000 | -6.2% | 1,225,632 | +23.1% | 0.08% | +6.3% |
| Q3 2018 | $19,908,000 | +4.6% | 995,319 | +2.0% | 0.08% | -9.2% |
| Q2 2018 | $19,026,000 | +21.0% | 975,748 | +25.0% | 0.09% | +17.6% |
| Q1 2018 | $15,728,000 | +52.5% | 780,531 | +0.3% | 0.07% | +39.6% |
| Q4 2017 | $10,316,000 | -14.2% | 778,488 | +19.5% | 0.05% | -29.3% |
| Q3 2017 | $12,025,000 | +24.2% | 651,708 | +23.9% | 0.08% | +21.0% |
| Q2 2017 | $9,679,000 | +124.5% | 525,989 | +175.1% | 0.06% | +113.8% |
| Q1 2017 | $4,311,000 | +201.9% | 191,178 | +431.7% | 0.03% | +163.6% |
| Q3 2015 | $1,428,000 | -42.5% | 35,955 | 0.0% | 0.01% | -42.1% |
| Q2 2015 | $2,483,000 | +133.4% | 35,955 | +84.7% | 0.02% | +137.5% |
| Q1 2015 | $1,064,000 | – | 19,465 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |